Loading…
Boardwalk Elixir, an e-liquid manufacturer based in Texas, was cited for manufacturing and distributing tobacco products without required premarket authorization under the Family Smoking Prevention and Tobacco Control Act. The company failed to comply with FDA jurisdiction requirements for e-liquid products containing nicotine, which are classified as tobacco products subject to premarket review and approval before commercial marketing in the United States. This violation was particularly significant given the March 2022 legislative expansion of FDA tobacco authority to include products containing nicotine from any source, not just tobacco-derived nicotine.